Caricamento...
Targeting oncogenic Notch signaling with SERCA inhibitors
P-type ATPase inhibitors are among the most successful and widely prescribed therapeutics in modern pharmacology. Clinical transition has been safely achieved for H(+)/K(+) ATPase inhibitors such as omeprazole and Na(+)/K(+)-ATPase inhibitors like digoxin. However, this is more challenging for Ca(2+...
Salvato in:
| Pubblicato in: | J Hematol Oncol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7789735/ https://ncbi.nlm.nih.gov/pubmed/33407740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-01015-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|